The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The use of cryoablation to overcome resistance to PD-1 blockade in unresectable melanoma.
 
Meghan Mooradian
Consulting or Advisory Role - AstraZeneca; Catalyst Pharmaceuticals; Immunai; Nektar
 
Florian J. Fintelmann
Research Funding - Boston Scientific
 
Howard E. Kaufman
Employment - Immuneering
Leadership - Immuneering
Stock and Other Ownership Interests - Immuneering
Honoraria - Society for Immunotherapy of Cancer
 
Mari Mino-Kenudson
Consulting or Advisory Role - AstraZeneca/MedImmune; H3 Biomedicine
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Elsevier
 
Jaimie Lynn Barth
No Relationships to Disclose
 
Aleigha Lawless
No Relationships to Disclose
 
Tatyana Sharova
No Relationships to Disclose
 
Riley Fadden
Consulting or Advisory Role - Apricity Health
 
Krista M. Rubin
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
 
Donald P. Lawrence
No Relationships to Disclose
 
Dennie T. Frederick
No Relationships to Disclose
 
Moshe Sade-Feldman
No Relationships to Disclose
 
Ryan J. Sullivan
Consulting or Advisory Role - alkermes; Asana Biosciences; AstraZeneca; Bristol-Myers Squibb; Eisai; Iovance Biotherapeutics; Merck; Novartis; OncoSec; Pfizer; Replimune
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BeiGene (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Strategia (Inst); Viralytics (Inst)